American Journal of Psychiatry Audio cover art

American Journal of Psychiatry Audio

American Journal of Psychiatry Audio

By: American Journal of Psychiatry
Listen for free

About this listen

 Each episode of AJP Audio brings you an in-depth look at one of the articles featured in that month's issue of The American Journal of Psychiatry, the official journal of the American Psychiatric Association. Wide-ranging interviews with article authors cover the background, rationale, main findings, and future implications of the research. This podcast is subject to the Terms of Use at ww.psychiatry.org. The views and opinions expressed in this podcast are those of the individual speakers only and do not necessarily represent the views of the American Psychiatric Association, its officers, trustees, or members. The content of this podcast is provided for general informational purposes only and is not intended as, and shall not be understood or construed as, medical or any other type of professional advice nor does it represent any statement of the standard of care. We strongly recommend that any listener follow the advice of physicians directly involved in their care and contact their local emergency response number for any medical emergency. The information within this podcast is provided as-is and is not guaranteed to be correct, complete, or accurate.Copyright 2021 American Psychiatric Association Hygiene & Healthy Living Physical Illness & Disease Science
Episodes
  • December 2025: Adjunctive Lumateperone in Patients With Major Depressive Disorder: Results From a Randomized, Double-Blind, Phase 3 Trial

    December 2025: Adjunctive Lumateperone in Patients With Major Depressive Disorder: Results From a Randomized, Double-Blind, Phase 3 Trial
    Dec 1 2025

    Dr. Suresh Durgam (Intra-Cellular Therapies, a Johnson & Johnson Company, Bedminster, NJ) joins AJP Audio to discuss a phase 3 randomized controlled trial looking at the use of the antipsychotic medication lumateperone as adjunctive to antidepressant therapy in the treatment of patients with major depressive disorder. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin discusses the rest of the December issue of the Journal.

    • 00:48 Durgam interview
    • 03:09 Mechanism of action
    • 04:44 Patient-reported outcomes
    • 06:31 Immediate clinical implications
    • 07:32 Limitations
    • 08:08 Further research
    • 09:25 Kalin interview
    • 09:38 Durgam et al.
    • 13:09 Lin et al.
    • 17:22 Brodsky et al.

    Transcript

    Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.

    Subscribe to the podcast here.

    Listen to other podcasts produced by the American Psychiatric Association.

    Browse articles online.

    How authors may submit their work.

    Follow the journals of APA Publishing on Twitter.

    E-mail us at ajp@psych.org
    Show More Show Less
    22 mins
  • November 2025: Contingency Management for Stimulant Use Disorder and Association With Mortality: A Cohort Study

    November 2025: Contingency Management for Stimulant Use Disorder and Association With Mortality: A Cohort Study
    Nov 1 2025

    Dr. Lara Coughlin (University of Michigan, Ann Arbor) joins AJP Audio to discuss a study looking the impact of contingency management on all cause mortality in patients with stimulant use disorder. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin discusses the rest of the November issue of the Journal.

    • 01:09 Coughlin interview
    • 02:05 Stimulant use disorder and contingency management
    • 04:37 Mortality
    • 05:12 Contingency management and "moral hazard"
    • 08:30 Clinical uptake of contingency management
    • 09:28 Broader applicability to psychiatric conditions
    • 10:31 Limitations
    • 11:39 Further research
    • 12:32 Kalin interview
    • 12:49 Coughlin et al.
    • 16:41 Yalcinbas et al.
    • 22:22 Na et al.

    Transcript

    Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.

    Subscribe to the podcast here.

    Listen to other podcasts produced by the American Psychiatric Association.

    Browse articles online.

    How authors may submit their work.

    Follow the journals of APA Publishing on Twitter.

    E-mail us at ajp@psych.org
    Show More Show Less
    27 mins
  • October 2025: Differential Effects of Ovarian Steroids in Women With and Without Premenstrual Dysphoric Disorder: A Replication and Extension of Findings

    October 2025: Differential Effects of Ovarian Steroids in Women With and Without Premenstrual Dysphoric Disorder: A Replication and Extension of Findings
    Oct 1 2025

    Dr. Shau-Ming Wei (National Institute of Mental Health, Bethesda, MD) joins AJP Audio to discuss a replication study looking at impact of hormone addback to a hormone suppression regimen for the treatment of premenstrual dysphoric disorder. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin discusses the rest of the October issue of the Journal.

    • 00:34 Wei interview
    • 02:59 PMDD
    • 04:22 Up and downsides of hormone suppression
    • 05:52 Hormone addback
    • 07:15 Limitations of the current study
    • 08:38 Further research
    • 10:42 Kalin interview
    • 10:58 Wei et al.
    • 15:25 Sanacora et al.
    • 20:07 Whittle et al.
    • 23:06 Cooper et al.

    Transcript

    Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.

    Subscribe to the podcast here.

    Listen to other podcasts produced by the American Psychiatric Association.

    Browse articles online.

    How authors may submit their work.

    Follow the journals of APA Publishing on Twitter.

    E-mail us at ajp@psych.org
    Show More Show Less
    27 mins
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.